Dirk Reinhardt

22.8k total citations
452 papers, 11.6k citations indexed

About

Dirk Reinhardt is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dirk Reinhardt has authored 452 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 206 papers in Hematology, 154 papers in Molecular Biology and 89 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dirk Reinhardt's work include Acute Myeloid Leukemia Research (192 papers), Acute Lymphoblastic Leukemia research (79 papers) and Hematopoietic Stem Cell Transplantation (42 papers). Dirk Reinhardt is often cited by papers focused on Acute Myeloid Leukemia Research (192 papers), Acute Lymphoblastic Leukemia research (79 papers) and Hematopoietic Stem Cell Transplantation (42 papers). Dirk Reinhardt collaborates with scholars based in Germany, Netherlands and United States. Dirk Reinhardt's co-authors include Ursula Creutzig, Michael Dworzak, Martin Zimmermann, Jan‐Henning Klusmann, Gertjan J.L. Kaspers, Jan Starý, Thomas Lehrnbecher, C. Michel Zwaan, Claudia Langebrake and Marry M. van den Heuvel‐Eibrink and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Dirk Reinhardt

423 papers receiving 11.3k citations

Peers

Countries citing papers authored by Dirk Reinhardt

Since Specialization

Citations

This map shows the geographic impact of Dirk Reinhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Reinhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Reinhardt more than expected).

Fields of papers citing papers by Dirk Reinhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Reinhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Reinhardt. The network helps show where Dirk Reinhardt may publish in the future.

Co-authorship network of co-authors of Dirk Reinhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Reinhardt. A scholar is included among the top collaborators of Dirk Reinhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Reinhardt. Dirk Reinhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Value of Molecular Genetic Measurable Residual Disease ( MRD ) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10 2025 ·European Journal Of Haematology ·(unknown), (unknown), Mareike Rasche, Martina Pigazzi, Claudia Tregnago, (unknown), Christiane Walter, Michael Dworzak, Nora Mühlegger, Nils von Neuhoff, Franco Locatelli, Dirk Reinhardt, Markus Schneider	1
2	Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms 2024 ·Nature Communications ·(unknown), Jurrian K. de Kanter, (unknown), Mark Verheul, (unknown), Markus J. van Roosmalen, Henrik Hasle, (unknown), Dirk Reinhardt, Michael Dworzak, Nora Mühlegger, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Bianca F. Goemans, Ruben van Boxtel	8
3	APAL2020SC Pediatric Acute Leukemia (PedAL) Screening Trial - Developing New Therapies for Relapsed Leukemias 2023 ·Blood ·Michele S. Redell, Todd A. Alonzo, Robert B. Gerbing, Jim J. Wang, Maureen M. O’Brien, Gwen Nichols, Laura Di Laurenzio, Sarah K. Tasian, C. Michel Zwaan, Dirk Reinhardt, E. Anders Kolb, Todd M. Cooper	1
4	Characteristics of FLT3-ITD and Efficacy of Sorafenib Treatment in Pediatric AML: A Report from AML-BFM Study Group 2023 ·Blood ·(unknown), (unknown), (unknown), (unknown), Nils von Neuhoff, Markus Schneider, Dirk Reinhardt, Naghmeh Niktoreh	2
5	Efficient Small Extracellular Vesicles (EV) Isolation Method and Evaluation of EV-Associated DNA Role in Cell–Cell Communication in Cancer 2022 ·Cancers ·(unknown), (unknown), (unknown), Katarina Reinhardt, Alexandra Brenzel, Márton Gelléri, Christoph Cremer, (unknown), Markus Schneider, Nils von Neuhoff, Dirk Reinhardt, Jadwiga Jabłońska, Irina Nazarenko, Basant Kumar Thakur	15
6	Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group 2022 ·Biomedicines ·(unknown), Pietro Merli, Christiane Walter, (unknown), (unknown), (unknown), Claudia Tregnago, Jonas Abrahamsson, Luisa Strocchio, Edwin Sonneveld, Linda Fogelstrand, Nils von Neuhoff, Dirk Reinhardt, Henrik Hasle, Martina Pigazzi, Franco Locatelli	4
7	The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis 2021 ·Blood ·(unknown), (unknown), R Bhayadia, Michelle Ng, (unknown), (unknown), Stephan Emmrich, (unknown), Christian Ihling, Andrea Sinz, Martin Zimmermann, Claudia Wickenhauser, (unknown), (unknown), Maurice Labuhn, Dirk Reinhardt, Marie‐Laure Yaspo, Dirk Heckl, Jan‐Henning Klusmann	24
8	Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter 2021 ·Children ·(unknown), (unknown), Dirk Reinhardt	10
9	Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia 2021 ·Cancers ·(unknown), (unknown), Christiane Walter, Naghmeh Niktoreh, Helmut Hanenberg, Nils von Neuhoff, Dirk Reinhardt, Markus Schneider	10
10	BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone 2021 ·Cancer Genetics ·Yvonne Lisa Behrens, Andrea Schienke, (unknown), Jana Lentes, Marcel Tauscher, Doris Steinemann, Mareike Rasche, (unknown), (unknown), Dirk Reinhardt, Brigitte Schlegelberger, Gudrun Göhring	3
11	Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group 2021 ·Cancers ·Mareike Rasche, (unknown), Martin Zimmermann, Jean‐Pierre Bourquin, Heidrun Boztug, (unknown), E. Anders Kolb, Thomas Lehrnbecher, Nils von Neuhoff, Naghmeh Niktoreh, Nora Mühlegger, Lucie Šrámková, Jan Starý, Christiane Walter, Ursula Creutzig, Michael Dworzak, Dirk Reinhardt	15
12	Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia Model 2020 ·Molecular Cancer Research ·(unknown), Stefanie Bertram, Helen Blair, Verena Börger, Guntram Büsche, (unknown), (unknown), Bernd Giebel, Olaf Heidenreich, (unknown), Laxmikanth Kollipara, (unknown), Albert Sickmann, Christiane Walter, Nils von Neuhoff, Helmut Hanenberg, Dirk Reinhardt, Markus Schneider, Mareike Rasche	2
13	MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML 2017 ·Oncogene ·(unknown), (unknown), Askar Obulkasim, Daria G. Valerio, Edwin Sonneveld, (unknown), Válerie de Haas, Dirk Reinhardt, M Zimmermann, Jan Trka, André Baruchel, Rob Pieters, Marry M. van den Heuvel‐Eibrink, C. Michel Zwaan, Maarten Fornerod	14
14	Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial 2016 ·Journal of Clinical Oncology ·Lars Tramsen, Emilia Salzmann‐Manrique, Konrad Bochennek, Thomas Klingebiel, Dirk Reinhardt, Ursula Creutzig, Lillian Sung, Thomas Lehrnbecher	37
15	Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004 2013 ·Blood ·Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Michael Dworzak, Gudrun Fleischhack, Norbert Graf, Thomas Klingebiel, Bernhard Kremens, Thomas Lehrnbecher, Christine von Neuhoff, J. Ritter, Annette Sander, André Schrauder, Arend von Stackelberg, Jan Starý, Dirk Reinhardt	123
16	Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium 2013 ·Journal of Clinical Oncology ·C. Michel Zwaan, Carmelo Rizzari, Françoise Méchinaud, (unknown), Thomas Lehrnbecher, Vincent H. J. van der Velden, Berna Beverloo, Monique L. den Boer, Rob Pieters, Dirk Reinhardt, Michael Dworzak, Julie Rosenberg, George Manos, Shruti Agrawal, Lewis C. Strauss, André Baruchel, Pamela Kearns	66
17	Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group 2013 ·Journal of Clinical Oncology ·Gertjan J.L. Kaspers, Martin Zimmermann, Dirk Reinhardt, Brenda Gibson, R. Y. J. Tamminga, Olga Aleinikova, (unknown), Michael Dworzak, Sy Ha, Henrik Hasle, Liisa Hovi, Alexei Maschan, Yves Bertrand, Guy Leverger, Bassem I. Razzouk, Carmelo Rizzari, Petr Smíšek, Owen Smith, Batia Stark, Ursula Creutzig	152
18	CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML‐BFM98 and 2004 2011 ·Pediatric Blood & Cancer ·Ursula Creutzig, Martin Zimmermann, Jean‐Pierre Bourquin, Michael Dworzak, Gudrun Fleischhack, Christine von Neuhoff, Annette Sander, André Schrauder, Arend von Stackelberg, J. Ritter, Jan Starý, Dirk Reinhardt	19
19	Granulocyte Colony-Stimulating Factor (G-CSF) Treatment of Childhood Acute Myeloid Leukemias That Overexpress the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated With a Higher Incidence of Relapse 2010 ·Journal of Clinical Oncology ·(unknown), (unknown), Martin Zimmermann, (unknown), Manuela Germeshausen, Nils von Neuhoff, C. Michel Zwaan, Katarina Reinhardt, Iris H.I.M. Hollink, Jan‐Henning Klusmann, Thomas Lehrnbecher, (unknown), Jan Starý, Michael Dworzak, Karl Welte, Ursula Creutzig, Dirk Reinhardt	47
20	Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia 2009 ·Blood ·Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann, Brian V. Balgobind, Susan T.C.J.M. Arentsen-Peters, Mariëlle Alders, André Willasch, Gertjan J.L. Kaspers, Jan Trka, André Baruchel, Siebold S.N. de Graaf, Ursula Creutzig, Rob Pieters, Dirk Reinhardt, C. Michel Zwaan	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact